AACE Patient Journey of Diabetes Technology Quiz
Test your diabetes technology knowledge with this 10-question quiz.
Begin by choosing an answer option, and then click "…
Thank You!
Thank you for sharing your feedback with us. Your input is truly valued, as it plays a vital role in shaping the future of AACE patient journeys.
…
AACE President, Scott D. Isaacs, MD, FACP, FACE, highlights key opportunities for health care professionals to expand their medical knowledge through AACE’s latest initiatives, including the 2025…
Listen to episode #481 of The Curbsiders Internal Medicine Podcast, featuring AACE President, Scott D. Isaacs, MD, FACP, FACE, as he shares essential pearls on navigating screening tests for diabetes…
The 2025 Consensus Statement on the Management of Multiple Endocrine Neoplasia Type 1 (MEN1) has been published in Endocrine Practice. Dr. Jaydira Del Rivero, Chair of the MEN1 Consensus…
Ozempic feet are characterized by sagging skin and reduced fat padding in the feet, which can occur with rapid weight loss. AACE President Scott D. Isaacs, MD, FACP, FACE, and AACE member Karl…
Over 38 million adults in the United States have diabetes, according to the Centers for Disease Control and Prevention. Furthermore, the prevalence of diabetes has been steadily rising, increasing…
Anti-obesity drugs are showing promise for a growing list of conditions. In The Wall Street Journal, AACE President Scott D. Isaacs, MD, FACP, FACE, discusses the expanding role of GLP-1…
As Ozempic and other GLP-1 weight-loss injections continue to gain popularity, users are reporting a curious side effect that has nothing to do with numbers on the scale: a dramatic shift in their…